Even if it eventually gets covered by funding, this is still kind of bad. Who gets to publish is basically decided at funding time, not on merits of a paper.
As a general view, I am not sure on the merits of this spesific event.
But also, why are commercial entities reviweing scientific papers and deciding merit?
Are their interests aligned with mine as a tax payer?